Kırıkkale İlinde Yaşayan Yaşlı Bireylerde Sarkopeni Taraması: Pilot Çalışma

Abstract

Amaç: Bu çalışmanın amacı Kırıkkale ilinde yaşayan 65 yaş ve üzeri yaşlı bireylerde sarkopeni sıklığını belirlemektir. Gereç ve Yöntemler: Çalışmaya Kırıkkale Hürriyet Aile Sağlığı Merkezine kayıtlı 572 yaşlı birey dahil edildi. Demografik veriler oldu formu kaydedildi. Yaşlı bireylerin, kognitif durumları Standardize mini-mental testle, fiziksel performans kısa fiziksel performans bataryasıyla, fiziksel aktiviteleri yaşlılar için fiziksel aktivite ölçeği ile, sarkopeni taraması sarkopeni tarama testiyle değerlendirildi, el kavrama gücü baseline dijital el dinamometresiyle ve kas kütleleri inbody120 biyoimpedans analiz cihazı ile ölçüldü. Bulgular: Çalışmada 572 yaşlı bireyden 31'inde (%5,4) sarkopeni olduğu, 19'unda (%3,3) ise şiddetli sarkopeni olduğu ortaya çıktı. Sarkopeni prevalansı %5,4 olarak bulundu. Semptomatik risk ve sarkopeni durumu bireylerin cinsiyetlerine göre incelendiğinde erkek bireylerin %94,4'ünün (186 kişi) sağlıklı, %5,6'sının (11 kişi) semptomatik risk durumunda olduğu görüldü. Sarkopeni durumu erkekler açısından değerlendirildiğinde %94,9'unun (187 kişi) sarkopeni riski taşımadığı, %3,6'sının (7 kişi) sarkopeni, %1,5'inin (3 kişi) şiddetli sarkopeni olduğu saptandı. Kadın bireylerde %89,9'unun (337 kişi) sağlıklı, %10,1'inin (38 kişi) semptomatik risk durumunda olduğu görüldü. Sarkopeni durumu kadınlar açısından değerlendirildiğinde ise, %94,4'ünün (354 kişi) sarkopeni riski taşımadığı, %1,3'ünün (5 kişi) sarkopeni, %4,3'ünün (16 kişi) şiddetli sarkopeni olduğu saptandı. Sonuç: Yaşlı bireylerde sarkopeni varlığı göz ardı edilmemeli ve gerekli önleyici tedbirler alınmalıdır. Ek olarak, sarkopeni riski taşıyan yaşlı yetişkinlerin uygun egzersiz programlarına katılmaları teşvik edilmelidir.

Keywords

• Yaşlı erişkinler
• sarkopeni
• kas kütlesi
• kas gücü

Supporting Institution

Bu çalışma Kirikkale Üniversitesi Bilimsel Araştırmalar Prejesi (BAP) tarafından desteklenmiştir. (Project Number: 2023/028).

Thanks

Kirikkale Üniversitesi BAP

SCREENING FOR SARCOPENIA IN OLDER ADULTS LIVING IN KIRIKKALE PROVINCE: A PILOT STUDY

Abstract

Objective: The aim of this study is to determine the prevalence of sarcopenia in individuals aged 65 and older residing in Kırıkkale province. Material and Methods: The study involved the assessment of 572 older adults registered at the Kırıkkale Hürriyet Family Health Center. Demographic data was collected through a case form. Cognitive status was assessed using the standardized mini-mental test, physical performance was assessed with the short physical performance battery, sarcopenia screening was conducted using the sarcopenia screening test, physical activities were measured using the physical activity scale for the elderly, handgrip strength was measured with the baseline digital hand dynamometer, and muscle masses were evaluated with the inbody120 bioimpedance analysis device. Results: The study revealed that out of 572 older adults, 31 (5.4%) had sarcopenia, with 19 (3.3%) of them having severe sarcopenia. The prevalence of sarcopenia was found to be 5.4%. When the symptomatic risk and sarcopenia status were examined according to the gender of the individuals, it was seen that 94.4% (186 people) of male individuals were healthy, and 5.6% (11 people) were at symptomatic risk. In terms of sarcopenia status, it was determined that 94.9% (187 individuals) of male individuals were not at risk of sarcopenia, 3.6% (7 individuals) had sarcopenia, and 1.5% (3 individuals) had severe sarcopenia. Among female individuals, 89.9% (337) were healthy, and 10.1% (38) were at symptomatic risk. In terms of sarcopenia status, 94.4% (354 people) of females were found to be at no risk of sarcopenia, 1.3% (5 people) had sarcopenia, and 4.3% (16 people) had severe sarcopenia. Conclusion: The existence of sarcopenia in older adults should not be overlooked, and necessary preventive measures should be taken. Additionally, older adults at risk of sarcopenia should be encouraged to participate in suitable exercise programs.

Keywords

• Older adults
• sarcopenia
• muscle mass
• muscle strength

Supporting Institution

The study was supported by Kirikkale University Scientific Research Projects (Project Number: 2023/028).

Thanks

Kirikkale University Scientific Research Projects

References

1. Ageing and health. Accessed date 12 September 2023. https://www.who.int/news-room/fact- sheets/detail/ageing-and-health
2. Miller RA. Extending Life: Scientific prospects and political obstacles. Milbank Q. 2002;80(1):155-174.
3. TÜİK Kurumsal. Accessed date 4 September 2023. https://data.tuik.gov.tr/Bulten/Index?p=%C4%B0statistik lerle-Ya%C5%9Fl%C4%B1lar-2022-49667&dil=1
4. TÜİK Kurumsal. Accessed date 12 September 2023. https://data.tuik.gov.tr/Bulten/Index?p=Nufus- Projeksiyonlari-2018-2080-30567
5. Kim KJ, Shin J, Choi J, et al. Association of geriatric syndromes with urinary incontinence according to sex and urinary-incontinence–related quality of life in older inpatients: A cross-sectional study of an acute care hospital. Korean J Fam Med. 2019;40(4):235-240.
6. Ulusoylar N, Günay FSD, Dokuzlar Ö, Okudur SK. The Frequency of Fall in Geriatric Syndromes. J Geriatr Sci. 2019;2(1):8-13.
7. Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women: J Am Geriatr Soc. 2007;55(5):769-774.
8. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059-1064.

9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412-423.
10. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16-31.
11. Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: A systematic review and meta-analyses. Age and Ageing. 2019;48(1):48-56.
12. Simsek H, Meseri R, Sahin S, et al. Prevalence of sarcopenia and related factors in community-dwelling elderly individuals. Saudi Med J. 2019;40(6):568-574.
13. Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of sarcopenia in community-dwelling japanese older adults. J Am Med Dir Assoc. 2013;14(12):911-915.
14. Champely S, Ekstrom C, Dalgaard P, et al. pwr: Basic Functions for Power Analysis. Published online March 17, 2020. Accessed date 23 November 2023. https://cran.r- project.org/web/packages/pwr/index.html
15. Di Monaco M, Castiglioni C, De Toma E, et al. Presarcopenia and sarcopenia in hip-fracture women: Prevalence and association with ability to function in activities of daily living. Aging Clin Exp Res. 2015;27(4):465-472.
16. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S240-252.
17. Landi F, Russo A, Liperoti R, et al. Midarm muscle circumference, physical performance and mortality: Results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr. 2010;29(4):441-447.
18. Pekcan DG. Beslenme durumunun saptanması. Accessed date 28 January 2025 chrome- extension://efaidnbmnnnibpcajpcglclefindmkaj/https://krt knadmn.karatekin.edu.tr/files/sbf/beslenme-durumunun- saglanmasi.pdf
19. Rolland Y, Czerwinski S, Van Kan GA, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433- 450.
20. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome: Curr Opin Clin Nutr Metab Care 2010;13(1):1-7.
21. Morley JE. Sarcopenia: Diagnosis and treatment. J Nutr Health Aging. 2008;12(7):452-456.
22. Kim TN, Park MS, Lim KI, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: Korean Sarcopenic Obesity Study. Clin Endocrinol. 2013;78(4):525-532.
23. Haidar SG, Kumar D, Bassi RS, Deshmukh SC. Average versus maximum grip strength: Which is more consistent? J Hand Surg Br. 2004;29(1):82-84.
24. Lukaski H, Johnson P, Bolonchuk W, Lykken G. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41(4):810-817.
25. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” J Psychiatr Res. 1975;12(3):189-198.
26. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-M94.
27. Lin MR, Hwang HF, Hu MH, Wu HD, Wang YW, Huang FC. Psychometric comparisons of the timed up and go, one-leg stand, functional reach, and Tinetti balance measures in community-dwelling older people. J Am Geriatr Soc. 2004;52(8):1343-1348.
28. Ayvat E, Kilinç M, Kirdi N. The Turkish version of the physical activity scale for the elderly (PASE): Its cultural adaptation, validation, and reliability. Turk J Med Sci. 2017;47:908-915.
29. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): Evidence for validity. J Clin Epidemiol. 1999;52(7):643- 651.
30. Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531-532.
31. AcikBilim_10243129.pdf. Accessed date 3 October 2023. https://acikbilim.yok.gov.tr/bitstream/handle/20.500.1281 2/212144/yokAcikBilim_10243129.pdf?sequence=-1
32. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes: SARC-F. J Cachexia Sarcopenia Muscle. 2016;7(1):28- 36.
33. Drey M, Ferrari U, Schraml M, et al. German Version of SARC-F: Translation, adaption, and validation. J Am Med Dir Assoc. 2020;21(6):747-751.
34. Yang L, Yao X, Shen J, et al. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol. 2020;130:110798.
35. Carvalho Do Nascimento PR, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies. Age and Ageing. 2021;50(6):1906- 1913.
36. Petermann‐Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99.
37. Dinç Ö, Protein alımı ve protein kalitesinin sarkopeni varlığı ile ilişkisi (tez). Gazimağusa. Doğu Akdeniz Üniversitesi; 2018.
38. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez‐ Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: Dual‐energy X ‐ray absorptiometry data from the N ational H ealth and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2013;61(6):974-980.
39. Porter Starr KN, McDonald SR, Bales CW. Obesity and physical frailty in older adults: A scoping review of lifestyle intervention trials. J Am Med Dir Assoc. 201;15(4):240-250.
40. Melekoğlu T, Arslan B. Association between lean mass and handgrip strength in older adults. J Physic Edu Sports Sci. 2019;17(2):188-198.